- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
8th grade Avg
|
Exhibit 23.1
Consent of Independent Registered Public Accounting Firm
We have issued our reports dated February 22, 2005, accompanying the consolidated financial statements included in the Annual Report of Tapestry Pharmaceuticals, Inc. on Form 10-K for the year ended December 29, 2004. We hereby consent to the incorporation by reference of said reports in the Registration Statements of Tapestry Pharmaceuticals, Inc. on Form S-8 (No. 333-05561), Form S-8 (No. 333-75551), Form S-8 (No. 333-52008), Form S-8 (No. 333-73470), Form S-8 (No. 333-120081), Form S-3 (No. 333-95522), Form S-3 (No. 333-29477), Form S-3 (No. 333-42419), Form S-3 (No. 33-78016), Form S-3 (No. 333-51070), Form S-3 (No. 333-82810), Form S-3 (No. 333-112774) and Form S-3 (No. 333-107817).
GRANT THORNTON LLP |
|
|
Denver, Colorado |
February 22, 2005 |